India's healthcare sector is rapidly adopting CAR T Cell therapy in India due to the rising prevalence of cancer and the urgent need for advanced treatment options. Premier medical institutions like the Tata Memorial Centre and the All India Institute of Medical Sciences (AIIMS) are leading the charge, conducting clinical trials and developing indigenous CAR T-cell products. Additionally, collaborations between Indian biotech firms and global pharmaceutical giants are expediting the development and accessibility of this therapy.
read more..